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Abstract: 
Purpose of review: We aim to integrate a selection of the most recent data on 
Trichomonas vaginalis (TV) origins, molecular cell biology and TV interactions 
with the urogenital tract microbiota with trichomoniasis symptoms and clinical 
management. 
Recent findings: Transcriptomics and proteomics datasets are accumulating 
facilitating the identification and prioritisation of key target genes to study TV 
pathobiology. Proteins involved in host sensing and cytoskeletal plasticity 
during TV amoeboid transformation were identified. TV was shown to secrete 
exosomes and a macrophage migration inhibitory factor-like protein that both 
influence host-parasite interactions. TV co-infections with Mycoplasma 
species and viruses were shown to modulate the inflammatory responses 
while TV interactions with various Lactobacillus species inhibit parasite 
interactions with human cells. TV infections were also shown to be associated 
with bacterial vaginosis (BV). A broader range of health sequelae is also 
becoming apparent. Diagnostics for both women and men based on 
molecular approaches are being refined, in particular for men.  
Summary: New developments in the molecular and cellular basis of TV 
pathobiology combined with data on the urogenital tract microbiota and 
immunology have enriched our knowledge in human-microbe interactions that 
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Trichomonas vaginalis (TV) is the most common non-viral sexually 
transmitted infection (STI) worldwide. The World Health Organisation 
estimated that in 2005 there were 248 million cases of TV and this had 
increased by 11.2% to 276.4 million cases in 2008 [1]. There is significant 
regional variation with the highest rates in the Americas with an incidence of 
177.7 per 1000 females and 180.6 per 1000 males aged 15 to 44 and a 
prevalence of 22% in females and 2.2% in males. This contrasts with South 
East Asia where the incidence is estimated at 40.3 per 1000 females and 50.1 
per 1000 males with a prevalence of 5.6% and 0.6% respectively. Notably TV 
is affecting primarily woman of disadvantaged populations in both affluent and 
resource limited countries and is still very much a neglected disease despite 
increasing awareness of its important health sequelae.  
The availability, for one TV strain, of a draft genome sequence and annotation 
[2] have stimulated numerous studies on the parasite population genetics and 
molecular basis of it pathobiology [3, 4]. These developments paralleled with 
studies on the urogenital microbiota and immunology will eventually converge 
to improve our knowledge of TV pathobiology and assist with prevention and 
treatment protocols. Here we present an initial integration of a selection of the 
most recent developments in basic research on the parasite molecular cell 
biology with its clinical symptoms and management. 
 
TV as a bird derived zoonosis? 
A number of different molecular phylogenies have surprisingly supported a 
close relationship between TV and parasites isolated from birds [5]. The two 
human parasites TV and Trichomonas tenax (TT, from the oral cavity) were 
thought for some time to be closely related to, and possibly derived from, 
each other [2, 5]. Molecular phylogenies established that TV and TT are more 
closely related to distinct species of Trichomonas isolated from birds then they 
are to each other (Figure 1). This suggests two independent zoonotic origins 
from birds for these two human parasites. Hence it will be of great interest to 
perform comparative studies of the genomes and host-parasite interactions 
between human and bird Trichomonas species to identify the molecular basis 
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of their respective pathobiologies. Thus TV is likely join the long list of human 
pathogens derived from birds [6]. These considerations further illustrate the 
importance of studying pathogens in an integrated way across the fields of 
medical and veterinary research [6].  
 
Genomics and allied omics 
The draft genome sequence data and annotation for one clinical TV strain 
uncovered a surprisingly large and highly repetitive genome for a microbial 
eukaryote (Table 1) [2, 4]. These data represent an invaluable source of 
information to study the epidemiology and molecular cell biology of host-TV 
interactions [3]. Only a selection of recent developments is discussed here 
and complementary reviews cover a broader range of issues [3, 4, 7-9]. Due 
to TV vast potential protein coding capacity (Table 1), transcriptomics and 
proteomics investigations are particularly pertinent to identify and prioritise the 
functional characterisation of key TV proteins enabling infections [3, 4].  
Two recent studies have initiated the global profiling of TV gene transcription 
in various in vitro growth conditions for two distinct TV strains using RNA-seq 
methodologies [10, 11]. Circa 30,000 genes were transcribed in the various 
tested conditions in each strain [10, 11] and a core set of about 20,000 genes 
was identified across the 11 conditions considered in one study [10]. 
Modulation of mRNA levels upon exposure to oxidative stress, binding to 
vaginal epithelial cells (VEC) or glucose restriction have identified hundreds of 
genes involved in responses to these environmental cues. These included 
genes mediating oxidant scavenging and cytoskeletal re-arrangements upon 
exposure to oxygen, binding to VEC or a combination of both [10], or amino 
acid metabolism upon glucose restriction [11]. Notably the combined 
exposure of TV to oxygen and VEC stimulated the broadest set of TvBspA 
genes up-regulation [10], consistent with the hypothesis that the largest gene 
family (911 genes) encoding candidate surface proteins are important in host-
TV interactions [12]. A selection of TvBspA genes are listed in Supplementary 
digital content 1 (SDC1), illustrating the striking variation of transcription for 
some genes between the two studied strains, possibly underlying antigenic 
variation [7, 12]. The modulation of the actin-based cytoskeleton upon contact 
to VEC at the transcription level was also highlighted [10]. TV trophozoites 
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binding to VEC rapidly differentiates into an amoeboid form maximising 
contact with host cells, a key step in the infection process (Figure 2). The 
fimbrin protein (an actin bundling protein) was recently shown to dramatically 
change its cellular distribution from the cell periphery in trophozoites to focal 
points co-localising with actin in the amoeboid form [13]. 
With a highly repetitive genome possessing numerous transposable elements 
(TE), it is important to highlight here the recent analyses of one family of TE 
(class II Tc1/mariner) and their impact on gene transcription across 94 TV 
isolates [14]. Several insertions of TE were demonstrated to reduce or abolish 
the transcription of neighbouring genes, suggesting that such TE driven 
mutations could have functional implications and contribute to adaptive 
evolution of the parasite [14]. Combining comparative genomics and 
transcriptomics across a number of strains will be required to assess the role 
of TE in mediating TV genetic and phenotypic diversity. 
An annotated genome also facilitates proteomics investigations and a number 
of such datasets have been published [3, 7, 9]. Here we consider the most 
recent data on surface proteins and cargo proteins of the secreted exosomes. 
 
Surface and secreted proteins and exosomes 
Surface and secreted proteins from the parasite are at the forefront of host-
parasite interactions; hence these proteins have attracted great interests [7-9]. 
Two recent insights into the molecular basis of host-parasite interactions are 
considered here.  
Gene annotations identified a total of 11 TV tetraspanin (TSP) proteins 
possessing the characteristic four transmembrane domain of TSPs and two 
strains transcribe slightly different set of these genes (SDC1). Based on the 
numerous role of TSP proteins in human and model systems in orchestrating 
cell adhesion, fusion, signalling, proliferation and migration and their status as 
markers of exosomes, identified TvTSP as important target proteins to study 
host-TV interactions [15, 16]. Cell surface proteomics confirmed three TvTSP 
proteins [15] and one TvTSP protein, TvTSP6, was functional investigated 
[16]. The TvTSP6 cellular re-distribution (from flagella to the main cellular 
body and large intracellular vesicles) upon TV binding to VEC and its role in 
regulating TV migration, makes it a prime target to further investigate how TV 
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sense and orchestrate its binding to, and migration through, human tissues 
during infection [16]. The TvTSP6 and the fimbrin re-localisation data [13] 
illustrate the dramatic cellular changes taking place in TV upon binding to host 
cells.  
The secretion of exosomes by TV was investigated through a combination of 
cellular and proteomics approaches and identified exosomes with cargo RNA 
and a total of 215 cargo proteins including TvTSP1 and 
TvBspA_TVAG_216280 [17], the most and second most highly transcribed 
genes of these two gene families, respectively, in the recent RNA-Seq data 
(SDC1). Remarkably, TV exosomes were shown to bind to host cells, to 
modulate the TV-TV binding and TV-VEC and TV-prostate cells binding 
properties and to have immunomodulatory properties making these 
microvesicles and their cargo proteins attractive targets to gain new insights 
into TV pathobiology [17]. These various data identify the two exosomal 
membrane proteins TvTSP1 and TvBspA_TVAG_216280 as potential 
antigens for vaccine developments [18].  
Another secreted factor likely to be important in modulating host-TV 
interactions is the TV macrophage migration inhibitory factor (TvMIF_ 
TVAG_219770) that was recently shown to be similar to human MIF and 
functionally investigated [19]. Notably the TvMIF gene is highly transcribed 
whereas a related pseudogene is not (SDC1). Functional characterisation of 
the TvMIF protein demonstrated that it was active in inhibiting macrophage 
migration, stimulating host cell signalling, was interacting with the human 
CD47 MIF receptor and increased the growth and migration through matrigel 
of both benign and prostate cancer cells [19]. The data also demonstrated an 
adaptive immune response to the TvMIF in TV positive patients, consistent 
with the protein being secreted during infections. Could different TV strains 
express variant TvMIF genes in response to this host response? If so this 
might rationalize the TvMIF pseudogene (SDC1). Taken together these data 
are consistent with TvMIF stimulating inflammation and host cell proliferation 
and could be responsible for the underlying TV association with aggressive 
prostate cancers [19]. 
 
TV-microbes interactions and their impact on host-TV relations 
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It is increasingly recognised that studying host-parasite-bacteria-virus 
complex interactions at mucosal surfaces represent an important new 
paradigm to comprehend the impact, positive and negative, of these 
interactions on human health and disease conditions, and TV is no exception 
[20](Figure 2). Three recent developments are of interest in this context.  
First TV interactions with Mycoplasma hominis have been shown in vitro to 
synergistically up-regulate macrophage pro-inflammatory responses [21]. The 
pro-inflammatory responses to the TV-Mycoplasma consortium on immune, 
and possibly epithelial, cells might be clinically relevant by contributing to 
various health sequelae associated with TV infections (see later sections). 
Notably a recent metagenomics investigations of the vaginal microbota led to 
the characterisation of the genome sequence of a new species of 
Mycoplasma that is strongly associated with TV infections [22]. This suggests 
that different TV-Mycoplasma consortia might exist. Could these lead to 
variations in inflammatory responses [21] and variations in TV gene 
transcription and protein synthesis profiles?  
Second, endogenous TV viruses (TVV) isolated as TV-TVV consortium from 
symptomatic female patients were also shown in vitro to stimulate pro-
inflammatory responses in human VEC [23]. Notably metronidazole 
treatments amplified the in-vitro pro-inflammatory responses in TVV positive 
parasites possibly due to the increase in TVV particles released from dying 
parasites. This phenomena could explain the negative impact of drug 
treatments observed during pregnancy [23](see later sections).  
Finally, the effect of different Lactobacilli in in vitro TV-VEC interactions assay 
was investigated and demonstrated that the bacteria mostly associated with 
healthy vaginal microbiota inhibited these interactions, consistent with 
protective functions of Lactobacilli species, with the exception of Lactobacillus 
pentosus, which enhanced TV adhesion to VEC [24]. These observations 
were shown to be Lactobacilli dose dependent [24]. Consistent with these 
data TV infections were shown to be associated with bacterial vaginosis, a 
dysbiosis characterised by the loss of protective Lactobacilli [25, 26].  
These different considerations suggest that diagnostics will need in the future 
to integrate TV, bacteria (mutualists and pathogens) and viruses (from both 
TV and humans) involved in the complex microbial ecology of the human 
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urogenital tracts, possibly by adapting metagenomics approaches currently 
exploited to characterise the complex host-microbiota-pathogens interactions 
e.g. [22]. So for example differentiating TV infections from TV-TVV, TV-
Mycoplasma or TV-TVV-Mycoplasma co-infections could benefit patients by 
pointing to differential treatments minimising inflammatory sequelae in those 
different contexts [23]. 
 
Impact on human health 
Previously regarded as a nuisance for women, it is now recognised that TV 
has a number of presentations in both genders, is a risk factor for HIV 
transmission and acquisition, as well as being associated with adverse 
pregnancy outcomes. TV infects the squamous epithelium of the genital tract, 
often including the female urethra. The usual symptoms of TV are vaginal 
discharge in women associated with vaginitis, cervicitis, and urethritis, 
although it is recognised that up to 1/3 women have no symptoms [27]. 
Recent studies have suggested an increased risk of acute endometritis in 
association with TV [28].  In men, TV is usually a transient infection and 
studies suggest up to 75% of men are asymptomatic but it may be associated 
with urethritis, rarely with balanitis [29] and possibly prostatitis [30]. A number 
of case reports suggest a widening of the pathologic spectrum of TV in 
humans including vulval ulceration [31], adult conjunctivitis [32] and 
pulmonary infections in association with HIV [33] and there is discussion 
around the possible contribution of TV to aggressive prostatic cancers [19, 
34].  
 
TV in pregnancy has been associated with low birth weight, premature rupture 
of membranes and preterm delivery [35, 36]. However some studies have 
failed to show that treatment of TV improves pregnancy outcome and some 
have indicated that treatment of TV infection in pregnancy may have a 
negative impact on the pregnancy [37, 38] - possibly explained by TVV 
inducing strong pro-inflammatory response upon drug treatment discussed 
earlier [23]. Neonatal infection, from vertical transmission with TV is rare. It 
usually causes a urogenital infection and there are case reports of vulvitis and 
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positive urine cultures in neonates. There are occasional reports of TV 
causing neonates respiratory tract infection [39].   
 
Multiple reports support an epidemiological association between HIV and TV.  
There is growing evidence that TV infection may enhance HIV transmission 
and acquisition and there may be an increased risk of TV infection in those 
that are HIV infected [40-42]. In women with vaginal TV who are HIV positive 
there is some evidence that TV may be more difficult to treat. A randomized 
clinical trial found that a 2g single oral dose of metronidazole was not as 
effective as 500mg of metronidazole twice daily for 7 days for trichomoniasis 
among HIV-infected women [43].    
 
Diagnostics 
The choice of specimen, diagnostic test and testing strategy for detection of 
TV will depend on the patient population, clinical setting, and the available 
laboratory facilities. In settings where there is a high prevalence of STIs 
nucleic acid amplification tests (NAATs) are now the test of choice where 
resources allow and have become the ‘gold standard’ offering the highest 
sensitivity for the detection of TV [44-47].  In settings where molecular testing 
is not available the diagnosis of TV infection remains problematic because 
wet mount microscopy alone performs poorly for the diagnosis of 
trichomoniasis in women. Wet mount microscopy and current rapid antigen 
detection tests are not suitable for diagnosis of trichomoniasis in men.  
 
A number of commercially available NAAT assays have sensitivities of 95–
100% and the specificity is also 95–100% depending on the specimen and 
reference standard.  The APTIMA TV Assay (Hologic Gen-Probe, San Diego, 
CA) was FDA-cleared in 2011 for use with urine, endocervical and vaginal 
swabs, and endocervical specimens collected in the Hologic PreserveCyt 
solution (ThinPrep) from females only. The BD ProbeTec Trichomonas 
Vaginalis Qx Amplified DNA Assay (Becton Dickinson, Franklin Lakes, NJ) 
launched in Europe (EU cleared) in 2012. The diagnosis of TV in men has 
been challenging given the low sensitivity of microscopy and lack of FDA 
clearance to date for any NAATs or point-of-care tests for use with male 
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specimens. Some laboratories have verified the performance characteristics 
of NAATs through a validation process for male urine specimens or penile-
meatal swabs [45].  
 
Culture, until recently, has been considered ‘the gold standard,’ with 
specificity approaching 100% but the sensitivity can be as low as 75% 
compared with molecular testing. Culture systems such as InPouch TV 
(BioMed Diagnostics, San Jose, CA) allow for direct inoculation, culture and 
microscopic examination. Such systems are useful when immediate 
transportation of specimens to the laboratory is not available. The specimen 
should be inoculated within an hour of collection to maintain viability of the 
parasite [46]. 
 
A number of point of care tests that detect TV antigens or nucleic acids have 
been recently developed that allow for extended time between specimen 
collection and testing and more flexible sample storage temperatures. 
Commercially available tests include the OSOM Trichomonas Rapid Test 
(Sekisui Diagnostics, California, USA) and the TV latex agglutination test 
(Kalon Biological, Surrey, UK) and the Affirm VPIII (Becton Dickinson, 
Maryland, USA).  The sensitivities of these tests are similar to culture and 
consistently higher than wet mount microscopy. The specificities range from 
92% to 100%. All three tests are intended for use with vaginal swabs from 
symptomatic women. However, none has been evaluated for screening 
asymptomatic women or for the diagnosis of TV in men. 
 
Traditionally the diagnosis of TV has been made by the detection of the motile 
parasites on a  wet mount preparation of vaginal or urethral secretions by 
light-field microscopy. Microscopy has the advantage that it is cheap, and can 
be performed near to the patient in a clinic setting.  The specificity with trained 
personnel is high. However specimens should be examined within 10 minutes 
and the sensitivity is reported to be as low as 45-60% in women and even 




Treatment for TV is with nitroimidazoles. As TV in women frequently infects 
the urethra and paraurethral glands and cure rates of around 50% with 
metronidazole intravaginal gel are reported, systemic treatment is required. A 
Cochrane review found a parasitological cure in >90% of cases of TV with 
almost any nitroimidazole drug given as a single oral dose or over a longer 
period [48].  Single dose treatments are associated with more frequent side 
effects than longer oral treatment.  Standard treatments are a 5 to 7 day 
course of metronidazole 400 to 500 mg twice daily or 2g of metronidazole or 
tinidazole as single dose [49, 50].  
 
Meta-analyses have concluded that there is no evidence of teratogenicity from 
the use of metronidazole in women during the first trimester of pregnancy [51]. 
Metronidazole can be used in all stage of pregnancy and during breastfeeding.  
Metronidazole enters breast milk and may affect its taste.  The manufacturers 
recommend avoiding high doses if breastfeeding or, if using a single dose of 
metronidazole, breastfeeding should be discontinued for 12-24 hours to 
reduce infant exposure.  Tinidazole is pregnancy category C (animal studies 
have demonstrated an adverse event) and its safety in pregnant women has 
not been well-evaluated.   
 
Persistent or recurrent TV may be due to inadequate therapy, re-infection, or 
resistance [52].  Development of resistance against nitroimidazoles can be 
due to aerobic and anaerobic resistance.  In the USA, it is estimated that 5% 
of clinical isolates of TV exhibit some degree of metronidazole resistance, 
predominantly low level [53].  In vitro resistance does not predict clinical 
response to treatment, as it may be relative rather than absolute, and may be 
overcome by high dose metronidazole or tinidazole therapy.  Clinical isolates 
resistant to metronidazole can be resistant to tinidazole but usually with 
significantly lower minimal lethal concentrations to tinidazole than 
metronidazole [54, 55]. 
 
Conclusion 
Molecular cell investigations, greatly facilitated by the availability of the 
genome sequence, have brought important new insights into TV pathobiology. 
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These developments combined with investigations on the microbiota and 
immunology of the urogenital tract have started to draw a more precise picture 
of the complex interplay between pathogens, the microbiota and the immune 
system. It is imperative to integrate these different data to improve our 
knowledge on human-microbe interactions to eventually improve our capacity 
to avoid and treat STIs that affect hundreds of millions of people of all ages, in 
particular those living in resource limited conditions.  
 
Key points: 
 Genomics, transcriptomics and proteomics datasets have started to 
boost research efforts characterising the molecular and cellular basis of 
TV pathobiology 
 Complex interplay between TV, bacteria and viruses are being 
uncovered 
 Future research efforts in the laboratory and the clinic will need to 
consider the complex interplay between TV, bacteria and viruses 
 Diagnostic and clinical management of TV will benefit from basic 
research  
 Improved diagnostic tests will enhance our understanding of the 
disease spectrum caused by TV 
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Figure 1. Molecular phylogeny identify bird parasites as sister taxa to 
TV. 
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Molecular phylogeny based on an Rpb1 (the largest subunit of the RNA-
polymerase II) protein alignment focusing on Trichomonadea are consistent 
with phylogenies derived from other genes - see Maritz et al. [5] for details 
including accession number of sequences. Species isolated from humans are 
highlighted with arrows; all other species were isolated from birds (bird 
species and country are indicated). Note one sequence derived from a bird 
isolate that is highly similar to TV sequences, which could represent a transfer 
from human to bird. 
 
Figure 2. Host-TV interactions and its interplay with other microbes 
A. Upon contact with human tissues (epithelial cells, extracellular matrix 
proteins [ECM]) TV trophozoites (pear-shaped cells) rapidly differentiate into 
amoeboid forms (pancake-like cells), dramatically increasing surface contact. 
This is one of the cellular processes thought to be essential for long-term 
infections [13, 20]. A combination of TV lipophosophglycans (LPG) and 
surface proteins mediate the binding to host tissues. Some TV proteins are 
delivered to the host cell surface via TV exosomes and thought to influence 
TV binding (see main text for these different points). B. Complex interplay 
between Bacteria, Viruses and Eukaryote in human-microbes interactions. 
The diagram illustrates a TV-infected pregnant woman and her partner in the 
global context of human-microbes interactions in their respective urogenital 
tracts. TV infections can affect the health status of both adults and the embryo 
(eg preterm birth and HIV transmission in utero). Other common eukaryotes 
encountered in the urogenital tract are Fungi of the genus Candida. TV, TVV, 
Mycoplasma, and other microbes can modulate the inflammatory status of the 
urogenital tracts and by doing can alter the susceptibility of a given individual 
to additional infectious agents such as HIV – see main text. Modified figure 
derived from [20]. 
 
Table 1. Some key features of the TV genome 
 
Supplementary Digital content 1 (SDC1). Comparison of transcript 
abundance between two different TV strains for selected genes. 
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  Trichomonas vaginalis* 59681 160 65 
  Homo sapiens 35845 2900 46 
  Drosophila melanogaster (fruit flie) 13679 180 2 
  Entamoeba histolytica* 9938 25 6 
  Giardia lamblia* 9649 12 ? 
  
      Subset of a table from reference [2] 
    *Microbial eukaryotes infecting mucosal surfaces 
   
       
Table 1
